Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Medicinal Chemistry

• Publication date

  2014-11-30

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.2174/0929867321666140716103130PMID 25039773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delivery of a lactose derivative of endomorphin 1 to the brain via the olfactory epithelial pathway.

  2014cited by this paper
• Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.

  2014cited by this paper
• Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport.

  2014cited by this paper
• Quantification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in rodent brain by UHPLC/ESI-Q-TOF-MS/MS after intra-nasal administration of curcuminoids loaded PNIPAM nanoparticles.

  2014cited by this paper
• Current status and future prospects of drug delivery systems.

  2014cited by this paper
• Nose-to-brain transport of aerosolised quantum dots following acute exposure

  2014cited by this paper
• Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.

  2014cited by this paper
• Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood.

  2014cited by this paper
• Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats.

  2014cited by this paper
• Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution.

  2014cited by this paper
• Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia.

  2014cited by this paper
• Intranasal delivery of chitosan-siRNA nanoparticle formulation to the brain.

  2014cited by this paper
• Differential Disruption of Blood–Brain Barrier in Severe Traumatic Brain Injury

  2014cited by this paper
• Nanoparticle mediated non-covalent drug delivery.

  2013cited by this paper
• Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats

  2013cited by this paper
• Comparative evaluation of the degree of pegylation of poly(lactic‐co‐glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide

  2013cited by this paper
• Nanoparticles for imaging and treating brain cancer.

  2013cited by this paper
• Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief

  2013cited by this paper
• Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies.

  2013cited by this paper
• Mesenchymal Stem Cell Transplantation Attenuates Brain Injury After Neonatal Stroke

  2013cited by this paper
• A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke

  2013cited by this paper
• Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.

  2013cited by this paper
• Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration.

  2013cited by this paper
• Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach

  2013cited by this paper
• Intranasal delivery of nerve growth factor attenuates aquaporins-4-induced edema following traumatic brain injury in rats.

  2013cited by this paper
• Nasal Administration of Recombinant Osteopontin Attenuates Early Brain Injury After Subarachnoid Hemorrhage

  2013cited by this paper
• Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.

  2013cited by this paper
• Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.

  2013cited by this paper
• Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration

  2013cited by this paper
• Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats.

  2012cited by this paper
• Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.

  2012cited by this paper
• Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.

  2012cited by this paper
• New Clathrin-Based Nanoplatforms for Magnetic Resonance Imaging

  2012cited by this paper
• Brain delivery of olanzapine by intranasal administration of transfersomal vesicles

  2012cited by this paper
• Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels

  2012cited by this paper
• Prevention of Traumatic Brain Injury-Induced Neuron Death by Intranasal Delivery of Nicotinamide Adenine Dinucleotide

  2012cited by this paper
• Intranasal delivery of biologics to the central nervous system.

  2012cited by this paper
• Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke

  2012cited by this paper
• Nanoparticle-mediated delivery of Neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of Neurotoxin

  2012cited by this paper
• Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route.

  2012cited by this paper
• Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration

  2011cited by this paper
• Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.

  2011cited by this paper
• In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain.

  2011cited by this paper
• Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery.

  2011cited by this paper
• Nanocomposites for Neurodegenerative Diseases: Hydrogel-Nanoparticle Combinations for a Challenging Drug Delivery

  2011cited by this paper
• Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG-PLA nanoparticles in Calu-3 cells.

  2011cited by this paper
• Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration.

  2011cited by this paper
• Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.

  2011cited by this paper
• Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route

  2011cited by this paper
• Antinociceptive properties of nasal delivery of neurotoxin-loaded nanoparticles coated with polysorbate-80.

  2011cited by this paper
• Nose-to-Brain Transport Pathways of Wheat Germ Agglutinin Conjugated PEG-PLA Nanoparticles

  2011cited by this paper
• The application of mucoadhesive polymers in nasal drug delivery.

  2010cited by this paper
• Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI.

  2010cited by this paper
• Quantitative analysis of safranal in saffron extract and nanoparticle formulation by a validated high-performance thin-layer chromatographic method.

  2010cited by this paper
• Novel membrane‐permeable contrast agent for brain tumor detection by MRI

  2010cited by this paper
• Micellar Nanocarriers: Potential Nose-to-Brain Delivery of Zolmitriptan as Novel Migraine Therapy

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

  2010cited by this paper
• Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology

  2010cited by this paper
• Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations.

  2010cited by this paper
• Formulation and evaluation of novel micellar nanocarrier for nasal delivery of sumatriptan.

  2010cited by this paper
• Telomerase inhibitors for the treatment of brain tumors and the potential of intranasal delivery.

  2010cited by this paper
• Erythropoietin in stroke: quo vadis

  2010cited by this paper
• Small Solutions for Big Problems: The Application of Nanoparticles to Brain Tumor Diagnosis and Therapy

  2009cited by this paper
• Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells.

  2009cited by this paper
• Nanoparticles for biomedical imaging

  2009cited by this paper
• Thyrotropin-releasing hormone d,l polylactide nanoparticles (TRH-NPs) protect against glutamate toxicity in vitro and kindling development in vivo.

  2009cited by this paper
• Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

  2009cited by this paper
• Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles

  2009cited by this paper
• Formulation and Characterization of Nanoemulsion-Based Drug Delivery System of Risperidone

  2009cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• Mucoadhesive microspheres for nasal administration of cyclodextrins

  2009cited by this paper
• A study of rivastigmine liposomes for delivery into the brain through intranasal route

  2008cited by this paper
• Drug delivery and nanoparticles: Applications and hazards

  2008cited by this paper
• Brain uptake of an anti-ischemic agent by nasal administration of microparticles.

  2008cited by this paper
• New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.

  2008cited by this paper
• Delivery of peptides to the brain: emphasis on therapeutic development.

  2008cited by this paper
• Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.

  2008cited by this paper
• Neuroprotection for ischemic stroke: past, present and future.

  2008cited by this paper
• Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.

  2008cited by this paper
• Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer.

  2008cited by this paper
• Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting

  2008cited by this paper
• Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.

  2008cited by this paper
• Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells

  2008cited by this paper
• UEA I-bearing nanoparticles for brain delivery following intranasal administration.

  2007cited by this paper
• Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

  2007cited by this paper
• Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.

  2007cited by this paper
• Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.

  2006cited by this paper
• Multivalent effects of RGD peptides obtained by nanoparticle display.

  2006cited by this paper
• Surface modification of gold and quantum dot nanoparticles with chitosan for bioapplications.

  2005cited by this paper
• Drug-induced aseptic meningitis in suspected central nervous system infections.

  2005cited by this paper
• Translocation of Inhaled Ultrafine Particles to the Brain

  2004cited by this paper
• Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats.

  2003cited by this paper
• The Simple Model Versus the Super Model: Translating Experimental Traumatic Brain Injury Research to the Bedside

  2001cited by this paper
• Polyethylene glycol-coated biocompatible surfaces.

  2000cited by this paper
• Blood-brain barrier biology and methodology.

  1999cited by this paper
• Biodegradation and distribution of water-soluble chitosan in mice.

  1999cited by this paper
• Evolving stroke and the ischemic penumbra

  1996cited by this paper
• Gene delivery into the central nervous system by nasal instillation in rats.

  1995cited by this paper
• Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat.

  1993cited by this paper

• A critical comparative insight on nanocarrier-based intranasal delivery of statins for neuroprotective applications.

  2026cites this paper
• The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases

  2025cites this paper
• Nanoparticles Navigating the Intranasal Route: Innovative Approaches in Neurodegenerative Diseases

  2025cites this paper
• Nose-to-brain delivery of quercetin-loaded chitosan nanoparticles improves post-traumatic stress disorder-like phenotypes in mice.

  2025cites this paper
• Advances in Aerosol Formulation for Targeted Delivery of Therapeutic Agents from Nose to Brain.

  2024cites this paper
• A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery

  2024cites this paper
• Nanotechnological advances in the treatment of epilepsy: a comprehensive review

  2024cites this paper
• To Explore Nasal-Brain Lymphatic System for Brain-Targeted Drug Delivery and to Treat Neurodegenerative Diseases.

  2024cites this paper
• A Comprehensive Review on the Nanotechnology-based Intranasal Drug Delivery Systems for Brain Targeting

  2024cites this paper
• Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease

  2024cites this paper
• Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport

  2024cites this paper
• Ion-activated In Situ Gel of Gellan Gum Containing Chrysin for Nasal Administration in Parkinson's Disease.

  2023cites this paper
• Nanoparticles: Taking a Unique Position in Medicine

  2023cites this paper
• Plant‐Derived Vesicle‐Like Nanoparticles as Promising Biotherapeutic Tools: Present and Future

  2023cites this paper
• Translational Considerations in the Development of Intranasal Treatments for Epilepsy

  2023cites this paper
• Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders

  2022cites this paper
• Peptide loaded polymeric nanoparticles by non-aqueous nanoprecipitation.

  2022cites this paper
• Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease

  2022cites this paper
• Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology

  2021cites this paper
• Augmented Brain Delivery of Cinnarizine Through Nanostructured Lipid Carriers Loaded in situ Gel: in vitro and Pharmacokinetic Evaluation

  2021cites this paper
• Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier

  2021cites this paper
• Augmented Brain Delivery of Cinnarizine Through Nanostructured Lipid Carriers Loaded in situ Gel: in vitro and Pharmacokinetic Evaluation

  2021cites this paper
• Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect

  2021cites this paper
• Current knowledge and challenges associated with targeted delivery of neurotrophic factors into the central nervous system: focus on available approaches

  2021cites this paper
• A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier

  2020cites this paper
• The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems.

  2020cites this paper
• Oral and Intra-nasal Administration of Nanoparticles in the Cerebral Ischemia Treatment in Animal Experiments: Considering its Advantages and Disadvantages

  2020cites this paper
• Nose-to-brain delivery of antipsychotics using nanotechnology: a review

  2020cites this paper
• Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System

  2020cites this paper
• Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating

  2020cites this paper
• Respiratory Health Effects of Exposure to Ambient Particulate Matter and Bioaerosols.

  2019cites this paper
• An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology‐based delivery systems: A novel approach to treating neurodegenerative disorders

  2019cites this paper
• Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH)

  2019cites this paper
• Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer’s disease using Box-Behnken design

  2019cites this paper
• Molecular dynamics approach for behavior assessment of chitosan nanoparticles in carrying of donepezil and rivastigmine drug molecules

  2019cites this paper
• Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson's Disease Model

  2019influential citation
• Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.

  2019cites this paper
• Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.

  2019cites this paper
• Analyzing Nanotheraputics Based Approaches For The Management Of Psychotic Disorders.

  2019cites this paper
• Formulation of polymeric nanoparticles of antidepressant drug for intranasal delivery.

  2019cites this paper
• Partitioning of dispersed nanoparticles in a realistic nasal passage for targeted drug delivery

  2018cites this paper
• Antiepileptic drugs: progress and development

  2018cites this paper
• NANOPARTICLES: A PROMISING DRUG DELIVERY APPROACH

  2018cites this paper
• Formulation of levodopa containing dry powder for nasal delivery applying the quality‐by‐design approach

  2018cites this paper
• A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation

  2018cites this paper
• Chapter 5 Synthetic Polymer-Based Nanoparticles : Intelligent Drug Delivery Systems

  2018cites this paper
• Intranasal drug delivery devices and interventions associated with post-operative endoscopic sinus surgery

  2018cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cites this paper
• Validation of an HPLC‐UV method for analysis of Kaempferol‐loaded nanoemulsion and its application to in vitro and in vivo tests

  2017cites this paper
• Noninvasive nanoparticle strategies for brain tumor targeting.

  2017cites this paper
• Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.

  2017cites this paper
• Synthetic Polymer-Based Nanoparticles: Intelligent Drug Delivery Systems

  2017cites this paper
• Antimicrobial Nanostructures for Neurodegenerative Infections

  2017cites this paper
• The Distribution and Elimination of Nanomaterials in Brain

  2017cites this paper
• Pharmaceutical Targeting of the Brain.

  2016cites this paper
• Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management

  2016cites this paper
• Grapefruit-derived Nanovectors Delivering Therapeutic miR17 Through an Intranasal Route Inhibit Brain Tumor Progression.

  2016cites this paper
• Advances in the field of soft tissue engineering: From pure regenerative to integrative solutions

  2016cites this paper
• Computer simulations of the interaction of human immunodeficiency virus (HIV) aspartic protease with spherical gold nanoparticles: implications in acquired immunodeficiency syndrome (AIDS)

  2016cites this paper
• Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma

  2016cites this paper
• Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain

  2015cites this paper
• The meninges: new therapeutic targets for multiple sclerosis.

  2015cites this paper
• Cell-surface glycan-lectin interactions for biomedical applications

  2015cites this paper